Share
Market Research Report

BRAIN CANCER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By IndicationGlioblastoma · Meningioma · Pituitary Tumors · and Others (Oligodendroglioma, Astrocytoma, etc.)
  • By Treatment TypeChemotherapy (Carmustine, Temozolomide, Combination Drugs (Lomustine, Procarbazine, and Vincristine)) · Targeted Therapy (Bevacizumab, Larotrectinib, Entrectinib, Others (Dinutuximab, Naxitamab-gqgk etc.)) · and Immunotherapy (Dostarlimab, Granulocyte-macrophage colony-stimulating factor, Pembrolizumab)
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In02 Mar 2026
  • Report CodeCMI9360
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

Market Segmentation

  • Indication Insights (Revenue, USD Mn, 2021 - 2033)

    • Meningioma
    • Glioblastoma
    • Pituitary Tumors
    • Others (Oligodendroglioma, Astrocytoma, etc.)

  • Treatment Type Insights (Revenue, USD Mn, 2021 - 2033)

    • Chemotherapy
      • Carmustine
      • Temozolomide
      • Combination Drugs (Lomustine, Procarbazine, and Vincristine)
    • Targeted Therapy
      • Bevacizumab
      • Larotrectinib
      • Entrectinib
      • Others (Dinutuximab, Naxitamab-gqgk etc.)
    • Immunotherapy
      • Dostarlimab
      • Granulocyte-macrophage colony-stimulating factor
      • Pembrolizumab

  • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

  • Regional Insights (Revenue, USD Mn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa